Researchers discover a possible reason for drug resistance in breast tumors
Researchers used Liquid STEM to study HER2 dimers in breast cancer cells, finding that a sub-population without these dimers may have self-renewing properties and be resistant to HER2-antibody therapy. This discovery could provide new insights into drug resistance and tumor growth.